FTC’s AI Health App Crackdown: What Investors Need to Know Now
The rapid proliferation of AI-powered health applications promises transformative improvements in patient care, but it also introduces complex…
AI’s HIPAA Challenge: Unseen Data Exposure Risks for Investors
The rapid integration of artificial intelligence into healthcare promises transformative advancements, yet it simultaneously casts a long shadow…
AI Health Equity: Unpacking Who Wins (and Loses) in Cardiac AI
The rapid integration of artificial intelligence into healthcare promises unprecedented advancements, yet it simultaneously raises critical questions about…
Meta Pixel Lawsuits: The Hidden Costs of Health Data Sharing
The digital transformation of healthcare, while promising unprecedented efficiencies and insights, has introduced a complex new frontier for…
15 AI Safety Criteria for Health Plan Vendor Evaluation
The promise of artificial intelligence in healthcare is vast, yet for payers, health systems, and investors, discerning genuine…
AI Health Products: 10 Red Flags for Investors
The promise of artificial intelligence in healthcare is immense, yet the landscape is fraught with peril for health…
23andMe’s Downfall: A Wake-Up Call for Health AI Investment
The recent genetic data breach at 23andMe, which led to its bankruptcy and the sale of its assets,…
Beyond Meta Pixel: Auditing Patient Portal Security for Investors
The digital transformation of healthcare, while promising unprecedented efficiencies and improved patient outcomes, has simultaneously introduced complex new…
AI Trust Crisis: Why 51% Patient Skepticism Threatens Safety
The rapid integration of artificial intelligence into healthcare promises transformative advancements, yet a significant hurdle persists: trust. When…
AI Health Transparency: Rating 15 Vendors for Investor Trust
The promise of artificial intelligence in healthcare is immense, yet its integration into clinical practice is fraught with…